Top Abstract Purchase Related
Home
>
Node
>
Subnode

Substantiation of the duration of m-cholinolytics administration in conservative treatment of hyperactive urinary bladder

Danilov, V.V.; Vol'nykh, I.I.; Danilova, T.I.; Vodop'ianova, O.A.; Kudriakova, N.A.

Urologiia 5: 71-74

2006

ISSN/ISBN: 1728-2985
PMID: 17444156
Document Number: 597878
The analysis of treatment outcomes in 74 patients with hyperactive urinary bladder (HUB) has shown that duration of the treatment depends on the initial function of the lower urinary tracts. There was a correlation between mean effective therapy and treatment duration. Estimation of this correlation allows prognosis of treatment efficacy and selection of optimal anticholinergic drug for correction of miction disorders. Spasmex proved to be the most adequate drug for long-term treatment due to minimal number of side effects and feasibility to vary dose and regimen of intake.

Document emailed within 1 workday
Secure & encrypted payments

Mazo, E.B.; Babanina, G.A. 2007: Trospium chloride (spasmex) in the treatment of lower urinary tract symptoms in patients with neurogenic hyperactive urinary bladder caused by vertebrogenic lesions Urologiia 2007(3): 15-19
Mazo, E.B.; Krivoborodov, G.G. 2005: Neurological aspect of the hyperactive urinary bladder syndrome Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 105(7): 58-62
Stockamp, K. 1974: The neuropathic bladder in childhood: urinary diversion or conservative treatment? Journal d'Urologie et de Nephrologie 80(12 Part 2): 295-298
Kojima, Y.; Tsujimura, A.; Uchida, K.; Wakatsuki, A.; Sakurai, T.; Yamamoto, T. 1991: Urinary bladder disturbances in cervical spondylosis: improvement after surgical and conservative treatment Hinyokika Kiyo. Acta Urologica Japonica 37(5): 497-501
Sánchez-Martín, F.M.; Palou Redorta, J.; Regalado Pareja, R.; Rubio Briones, J.; Villavicencio Mavric, H.; Vicente Rodríguez, J. 1999: BCG and radiotherapy: the compatibility of 2 conservative treatments for cancer of the urinary bladder Archivos Espanoles de Urologia 52(7): 749-758
Mikol'ian, V.K.; Kaladze, N.N. 1987: Clinico-immunologic substantiation of the duration of sanatorio-health resort treatment of children with rheumatoid arthritis Pediatriia 7: 37-40
Lijinsky, W.; Taylor, H.W. 1975: Induction of urinary bladder tumors in rats by administration nitrosomethyldodecylamine Cancer Research 35(4): 958-961
Labat, J.-J. 2005: Needs and waiting for better management of hyperactive bladder Annales d'Urologie 39(Suppl 6): S192-S195
Svet-Moldavskiĭ, G.I.; Turusov, V.A.; Osipova, T.V. 1975: Transplantable cancer of the urinary bladder and hemangiopericytoma obtained by means of the ectopic transplantation of tissues of the fetal urinary bladder Voprosy Onkologii 21(9): 89-93
Nishino, T.; Katayama, K.; Takahashi, Y.; Tanaka, T. 2012: A case of sigmoid colon cancer invading urinary bladder treated with preoperative mFOLFOX6 and urinary bladder conserving surgery Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(2): 301-304
Becci, P.J.; Thompson, H.J.; Grubbs, C.J.; Brown, C.C.; Moon, R.C. 1979: Effect of delay in administration of 13-cis-retinoic acid on the inhibition of urinary bladder carcinogenesis in the rat Cancer Research 39(8): 3141-3144
Murase, T.; Kobayashi, O.; Aota, Y.; Mitsuta, H.; Koshikawa, T. 1983: Histological study of urinary bladder tumor: DNA of rat urinary bladder tumor caused by N-butyl-N-(4-hydroxybutyl) nitrosamine and that of human bladder tumor Hinyokika Kiyo. Acta Urologica Japonica 29(3): 303-310
Frith, C.H.; Rule, J.E. 1978: The effects of discontinuing administration of high levels of 2-acetylaminofluorene on the transitional epithelium of the mouse urinary bladder Journal of Environmental Pathology and Toxicology 1(5): 581-585
Pena Outeiriño, J.M.; Leal López, A.; Villodres Duarte, A.; Torrubia Romero, F.J. 1987: Ureterohydronephrosis in patients with neurogenic bladder: conservative treatment Archivos Espanoles de Urologia 40(5): 337-341
Acebal Lucía, J.; Paez Borda, A.; Llorente Abarca, C.; Quijano Barroso, P.; Herrero Payo, A.; Bustamante Alarma, S.; Montes Díaz, M.J.; Berenguer Sánchez, A. 1995: Conservative treatment of muscle-infiltrating bladder tumors with TUR Archivos Espanoles de Urologia 48(6): 579-585
Tsukagoshi, S. 2003: ImmuCyst intravesical (freeze-dried preparation made from the connaught strain of Bacillus Calmette Guérin) for the treatment of superficial bladder cancer and carcinoma in situ of urinary bladder Gan to Kagaku Ryoho. Cancer and ChemoTherapy 30(7): 1027-1038
Krivoborodov, G.G.; Mazo, E.B.; Shvarts, P.G. 2002: Afferent stimulation of the tibial nerve in patients with hyperactive bladder Urologiia 2002(5): 36-39
Gruenwald, I.; Stein, A.; Lurie, A. 1995: Conservative treatment of superficial transitional cell carcinoma of the bladder Harefuah 128(2): 104-111
Hulewicz, G.; Roy, P.; Coquard, R.; Saleh, M.; Marechal, J.M.; Dubernard, P.; Gilly, F.N.; Romestaing, P.; Ardiet, J.M.; Sentenac, I.; Gerard, J.P. 1997: Peroperative radiotherapy in the conservative treatment of infiltrating bladder cancers Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 7(2): 229-234
Villà Freixa, S. 1999: Combination chemotherapy and radiotherapy in the conservative treatment of infiltrating bladder carcinoma Archivos Espanoles de Urologia 52(6): 614-624